Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Mar 29;149(5):418-424.
doi: 10.1093/ajcp/aqy002.

Limited Utility of Fluorescence In Situ Hybridization for Recurrent Abnormalities in Acute Myeloid Leukemia at Diagnosis and Follow-up

Ferrin C Wheeler  1 , Annette S Kim  2 , Claudio A Mosse  1 , Aaron C Shaver  1 , Ashwini Yenamandra  1 , Adam C Seegmiller  1
Affiliations

Limited Utility of Fluorescence In Situ Hybridization for Recurrent Abnormalities in Acute Myeloid Leukemia at Diagnosis and Follow-up

Ferrin C Wheeler et al. Am J Clin Pathol. .

Abstract

Objectives: Acute myeloid leukemia (AML) is classified in part by recurrent cytogenetic abnormalities, often detected by both fluorescent in situ hybridization (FISH) and karyotype. The goal of this study was to assess the utility of FISH and karyotyping at diagnosis and follow-up.

Methods: Adult AML samples at diagnosis or follow-up with karyotype and FISH were identified. Concordance was determined, and clinical characteristics and outcomes for discordant results were evaluated.

Results: Karyotype and FISH results were concordant in 193 (95.0%) of 203 diagnostic samples. In 10 cases, FISH detected an abnormality, but karyotype was normal. Of these, one had a FISH result with clinical significance. In follow-up cases, 17 (8.1%) of 211 showed FISH-positive discordant results; most were consistent with low-level residual disease.

Conclusions: Clinically significant discordance between karyotype and AML FISH is uncommon. Consequently, FISH testing can safely be omitted from most of these samples. Focused FISH testing is more useful at follow-up, for minimal residual disease detection.

PubMed Disclaimer

References

    1. Arber DA, Orazi A, Hasserjian R et al. . The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127:2391-2405. - PubMed
    1. O’Donnell MR, Abboud CN, Altman J et al. . NCCN clinical practice guidelines: acute myeloid leukemia. J Natl Compr Canc Netw. 2012;10:984-1021. - PubMed
    1. Vardiman JW, Thiele J, Arber DA et al. . The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood. 2009;114:937-951. - PubMed
    1. Patel JP, Gönen M, Figueroa ME et al. . Prognostic relevance of integrated genetic profiling in acute myeloid leukemia. N Engl J Med. 2012;366:1079-1089. - PMC - PubMed
    1. Papaemmanuil E, Gerstung M, Bullinger L et al. . Genomic classification and prognosis in acute myeloid leukemia. N Engl J Med. 2016;374:2209-2221. - PMC - PubMed